Grapefruit and grapefruit-containing products may interact with capivasertib, potentially triggering adverse reactions. Refrain from consuming any gra···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 111
Seek immediate emergency medical assistance or contact the Poison Control Helpline.【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 113
Take the medication as soon as you remember. However, if it has been more than 4 hours since your scheduled dose, skip the missed one. Do not take a d···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 114
Capivasertib, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal g···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 112
Capivasertib, a breast cancer treatment targeting a specific gene abnormality, has demonstrated significant clinical efficacy. Like many other medicat···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 102
To help patients better understand and correctly use capapasetinib, the following detailed dosage guidelines are provided to ensure effective treatmen···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 111
The price of capapasetinib is affected by dosage, region, and purchase channel. Currently, there is no publicly announced uniform price in China. In o···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 105
Capivasertib (generic name: Capivasertib) is not yet officially available in the Chinese market. Actual costs are significantly affected by dosage, pu···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 106
Novartis recently announced updated results from its landmark COMBI-AD clinical trial, demonstrating that in patients with high-risk stage III BRAF-mu···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 110
On June 22, 2017, the U.S. Food and Drug Administration (FDA) approved the combination of dabrafenib and trametinib (DABRAFENIB® and TRAMETINIB®, Nova···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 110
The U.S. Food and Drug Administration (FDA) has approved dabrafenib (TAFINLAR®, Novartis Pharmaceuticals Corp.) and trametinib (MEKINIST®, Novartis Ph···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 105
According to the American Cancer Society, breast cancer is the most common cancer among women in the United States. HR-positive breast cancer (express···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 99
AstraZeneca recently announced positive results from the Phase 3 CAPItello-281 clinical trial. The analysis showed that in patients with PTEN-deficien···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 94
AstraZeneca recently announced positive top-line results from the Phase 3 CAPItello-291 trial. This global, double-blind, randomized Phase 3 study for···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 99
Belzutifan may be affected by other medications, including prescription drugs, over-the-counter products, vitamins, and herbal supplements. Inform you···【Read More】
Update: 2026-04-02Source: Haiou HealthViews: 111
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos



